Advertisement

Mineralstoffpräparate und Osteoporosemittel

  • Ulrich Schwabe
  • Reinhard Ziegler

Zusammenfassung

Hauptvertreter der Mineralstoffpräparate sind Calcium-, Kalium- und Magnesiumpräparate. Kaliumpräparate dienen der Korrektur eines höhergradigen Kaliummangels. Magnesiumpräparate sind bei Magnesiummangelzuständen indiziert die aber bei der weiten Verbreitung von Magnesium in der Nahrung bei üblicher Kost selten sind.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. American Medical Association (1986): Agents affecting calcium metabolism. In: Drug Evaluations, 6th ed, Saunders Company, Philadelphia, pp. 827–839, 885–902.Google Scholar
  2. Arzneimittelkommission der Deutschen Ärzteschaft (2003): Empfehlungen zur Therapie und Prophylaxe der Osteoporose. Arzneiverordnung in der Praxis (Sonderheft 34S).Google Scholar
  3. Bone HG, Greenspan SL, McKeever C et al (2000): Alendronate and estrogen effects in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab 85: 720–726.PubMedCrossRefGoogle Scholar
  4. Crowther CA, Hiller JE, Doyle LW, Haslam RR (2003): Effect of magnesium sulfate given for neuroprotection before preterm birth. JAMA 290:2669–2676.PubMedCrossRefGoogle Scholar
  5. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997): Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670–676.PubMedCrossRefGoogle Scholar
  6. Fleisch H (2000): Bisphosphonates in bone disease. From the laboratory to the patient. 4th ed, Academic Press, San Diego etc., pp. 1–212.CrossRefGoogle Scholar
  7. Galloe AM, Rasmussen HS, Jorgensen LN, Aurup P, Balslov S et al (1993): Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction. Brit Med J 307:585–587.PubMedCrossRefGoogle Scholar
  8. Hersh AL, Stefanick ML, Stafford RS (2004): National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. JAMA 291: 47–53.PubMedCrossRefGoogle Scholar
  9. ISIS-4 Collaborative Group (1995): ISIS-4: a randomised Arctoriol trial assessing early oral Captopril, oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345:669–685.CrossRefGoogle Scholar
  10. Kuhlmann U, Siegenthaler W, Siegenthaler G (1987): Wasser-und Elektrolythaushalt. In: Siegenthaler W. (Hrsg): Klinische Pathophysiologie. Georg Thieme Verlag, Stuttgart New York, S. 209–237.Google Scholar
  11. Manz M, Mletzko R, Jung W, Lüderitz B (1990): Behandlung von Herzrhythmusstörungen mit Magnesium. Dtsch Med Wschr 115: 386–390.PubMedCrossRefGoogle Scholar
  12. Meyer P, Boettger MB (2001): Familial hypomagnesaemia with second hypocalcemia: A new case that indicates autosomal recessive inheritance. J Inherit Metab Dis 24: 875–876.PubMedCrossRefGoogle Scholar
  13. Miller PD, Watts NB, Licata AA et al (1997): Cyclical etidronate in treatment of postmenopausal osteoporosis. Am J Med 103:468–476.PubMedCrossRefGoogle Scholar
  14. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al (2001): Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441.PubMedCrossRefGoogle Scholar
  15. NIH Consensus Conference (1994): Optimal calcium intake. JAMA 272:1942–1948.CrossRefGoogle Scholar
  16. Riggs BL, O’Fallon WM, Lane A, Hodgson SF, Wahner HW et al (1994): Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis. J Bone Miner Res 9: 265–275.PubMedCrossRefGoogle Scholar
  17. Wüster C, Ziegler R (1993): Fluorid-Therapie der Osteoporose: „Auf die Dosis kommt es an“. Dtsch Ärztebl 90: B-41–42.Google Scholar
  18. Zehender M, Meinertz T, Faber T, Caspary A, Jeron A et al (1997): Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. J Am Coll Cardiol 29:1028–1034.PubMedCrossRefGoogle Scholar
  19. Ziegler R (2002): Osteoporose: aktuelle Diagnostik und Therapie. Orthopädische Praxis 38: 570–577.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Ulrich Schwabe
    • 1
  • Reinhard Ziegler
    • 2
  1. 1.Pharmakologisches Institut der Universität HeidelbergHeidelberg
  2. 2.Heidelberg

Personalised recommendations